Loading...
5 view(s)
ACON Laboratories Announces Breakthrough 4-in-1 Flowflex® Plus RSV + Flu A/B + COVID Home Test
ACON Laboratories, Inc., a leading global medical device manufacturer, announced today that its Flowflex® Plus RSV + Flu A/B + COVID Home Test has received 510(k) clearance from the U.S. Food & Drug Administration (FDA). The Flowflex Plus RSV + Flu A/B + COVID Home Test (K251749) is an over-the-counter (OTC) rapid antigen test that can be administered in the comfort and privacy of consumers’ homes. This new test will be manufactured domestically in ACON’s state-of-the-art facility in San Diego, CA.
